How to Target Estrogen Receptor-Negative Breast Cancer?

Endocrine-Related Cancer- United Kingdom

doi 10.1677/erc.0.0100261

Full Text

Abstract

Available in

Date

Authors

Publisher

Bioscientifica

Related search

Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment

Oncotarget
Oncology
2018English

Estrogen Receptor-Negative Breast Cancer: New Insights Into Subclassification and Targeting

Clinical Cancer Research
Cancer ResearchOncology
2009English

Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor-Negative Breast Cancer

Cancer Research
Cancer ResearchOncology
2010Spanish

CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer

Scientific Reports
Multidisciplinary
2020English

Dicer Expression in Estrogen Receptor–positive Versus Triple-Negative Breast Cancer: An Antibody Comparison

Human Pathology
Forensic MedicinePathology
2016Breton

Estrogen Receptor Beta Participate in the Regulation of Metabolizm of Extracellular Matrix in Estrogen Alpha Negative Breast Cancer.

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2010English

Increased CpG Methylation of the Estrogen Receptor Gene in BRCA1-linked Estrogen Receptor-Negative Breast Cancers

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor-Positive Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy